330 North Wabash Avenue |
|
Suite 2800 |
|
Chicago, Illinois 606011 |
|
Tel: +1.312.876.7700 Fax: +1.312.993.9767 |
|
www.lw.com |
|
|
|
FIRM/AFFILIATE OFFICES |
|
Austin |
Milan |
Beijing |
Munich |
Boston |
New York |
Brussels |
Orange County |
Chicago |
Paris |
Dubai |
Riyadh |
Dusseldorf |
San Diego |
Frankfurt |
San Francisco |
Hamburg |
Seoul |
Hong Kong |
Silicon Valley |
Houston |
Singapore |
London |
Tel Aviv |
Los Angeles |
Tokyo |
Madrid |
Washington, D.C. |

May 8, 2026
Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra, Florida, 32801
Re: Registration Statement on Form S-8; 3,831,831 shares of Common Stock, par value $0.001 per share
To the addressee set forth above:
We have acted as special counsel to Treace Medical Concepts, Inc., a Delaware corporation (the “Company”), in connection with the registration by the Company of 3,831,831 shares of common stock of the Company, par value $0.001 per share (the “Shares”), issuable under the Company’s 2021 Incentive Award Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (the “ESPP,” and together with the 2021 Plan, the “Plans”). The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on May 8, 2026 (the “Registration Statement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the related prospectus, other than as expressly stated herein with respect to the issue of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters
